Skip to main content

Theseus Pharmaceuticals, Inc. (THRX)

NASDAQ: THRX · IEX Real-Time Price · USD
16.10 -2.20 (-12.02%)
Nov 29, 2021 11:07 AM EST - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
0.880.82
Research & Development
5.964.12
Operating Expenses
6.844.94
Operating Income
-6.84-4.94
Other Expense / Income
5.162.24
Pretax Income
-12-7.18
Net Income
-12-7.18
Net Income Common
-12-7.18
Shares Outstanding (Basic)
10
Shares Outstanding (Diluted)
10
Shares Change
373.03%-
EPS (Basic)
-15.95-45.18
EPS (Diluted)
-15.95-45.18
Free Cash Flow Per Share
-6.45-30.24
EBITDA
-12-7.18
EBIT
-12-7.18
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).